Our Team

Entrepreneurial and intuitive, Miriam founded mdgroup in 2002. Today mdgroup is a digital and patient health services business offering a range of personalised services to support clinical trials on a global scale.

As Executive Chair of our board, Miriam uses her extensive industry experience to inspire a culture of ‘putting patients first’ – ensuring patients’ needs are top of mind in everything the team does.

Miriam’s success is reflected in her desire to help others achieve the same. As Chair of Women in Business European Council for WEConnect Europe, she tirelessly champions women-led enterprise, education and networking. Through our charity and as a trustee of the MD Educational Foundation, Miriam shares her own personal journey from finding her way as a school-leaver to establishing her own successful business, where she mentors and strives to inspire this entrepreneurial spirit.

Tarquin is a creative, solutions-focused leader with a passion for transforming the patient experience in clinical trials. As CEO, he takes an entrepreneurial and dynamic approach to expanding mdgroup’s reach, constantly challenging the status quo to drive innovation in decentralised and hybrid trial design.

With over 20 years of experience in senior roles across healthcare and clinical research, Tarquin has witnessed first-hand how traditional trials often fail to prioritise the patient. Determined to change this, he has led mdgroup in pioneering patient-first solutions, combining exceptional care with cutting-edge technology. Since joining in 2014, he has overseen the company’s significant growth, launching award-winning services and sister companies, Seacole Health and Horreum.

Tarquin ensures mdgroup remains at the forefront of clinical services development, delivering industry-leading solutions worldwide. His expertise lies in blending human interaction with technology to create more accessible, inclusive, and effective clinical trials.

Peter is a distinguished senior life sciences executive with over 25 years of comprehensive experience. He has a proven track record of leading global teams within sponsor organisations and contract research organisations (CROs).

Recognised as a PharmaVoice Top 100 leader, Peter is renowned for fostering highly effective collaborations between sponsors, CROs, investigator sites, and patient advocacy groups. His commitment to advancing research is further demonstrated through his roles on councils and advisory boards supporting Parkinson’s disease research and policy initiatives.

Based in Paris since 2019, Peter brings a wealth of international expertise to the teams he leads, enhancing global perspectives and operational excellence.

With over 20 years of experience in global drug development, Ian brings invaluable insight to our board as a Non-Executive Director. His expertise spans biotech, pharma, CROs, and health-tech sectors, with a strong track record in delivering patient-focused solutions across multiple therapeutic areas, including rare diseases, oncology, and respiratory conditions. He has successfully guided drug development from pre-IND through phase IV across the US, Europe, and Japan.

A PhD scientist with deep operational and regulatory expertise, Ian excels at translating complex challenges into actionable strategies. His leadership spans CMC, clinical operations, quality, and project management, ensuring success at every stage of development. Having worked closely with mdgroup as a client, Ian brings a unique perspective that allows him to think creatively about our products and services, identifying opportunities for innovation and growth.

With a passion for advancing health-tech solutions, Ian is committed to helping organisations expand their market share, enhance their offerings, and drive meaningful change in drug development and clinical research.

David is a Development Operations expert with 30 years of global experience in clinical development across a wide range of therapeutic areas. His career spans leadership roles in some of the largest pharmaceutical and biotech companies, as well as contract research organisations and start-ups. As a Non-Executive Director, he brings strategic insight into optimising operations and ensuring the seamless execution of drug development programmes.

David has a proven track record of leading operations through key transitions, from early research to product approval and beyond. He has successfully built and led teams through IND, CTA, BLA, and NDA filings, as well as post-marketing line extensions. With direct contributions to the success of global products such as Rituxan, Adcetris, Velcade, Truvada, Orbactiv, Pirfenidone, and Celebrex, he has played a pivotal role in bringing life-changing treatments to market.

With deep expertise in regulatory compliance, programme execution, and operational strategy, David provides invaluable leadership in helping organisations navigate the complexities of clinical development and maximise their impact.

Scott is a versatile leader with a strong track record of delivering innovative product and market strategies in the life sciences and healthcare software sectors. With a solid understanding of clinical, technological, and business fundamentals, he’s passionate about creating breakthrough solutions that meet the evolving needs of the industry.

He has extensive experience in the clinical development process, specialising in late-phase trials, post-market surveillance, and direct-to-patient initiatives. Scott is also highly knowledgeable in M2M (machine-to-machine) solutions for the life sciences, pharmaceutical, and healthcare markets. His results-driven approach blends sales and operational planning with agile methods for new product development.

Throughout his career, Scott has worked with organisations ranging from start-ups to global Fortune 100 companies, building expertise in sales, marketing, operations, and product strategy. He’s passionate about aligning product development with strategic goals and spotting opportunities to drive meaningful results.

Rebecca brings over 23 years of expertise in clinical trials operations within the pharmaceutical and clinical research sectors. Most recently, she served as Executive Director and Head of Global Clinical Operations at Allucent, where she led a large, multi-regional department spanning North America, Europe, the Middle East, and Asia Pacific. Her proven ability to establish innovative processes has significantly enhanced patient-centric approaches, notably during her tenure at Vault Health, where she developed decentralised clinical trial processes prioritising the patient experience.

Rebecca holds a Master’s in Biomedical Sciences from King’s College London and a Bachelor’s in Biomedical Sciences from the University of Wales, Cardiff. Her wealth of experience and unwavering commitment to patient care make her an invaluable addition to our mdgroup executive team.

Chris Prantl is a meticulous data privacy and compliance professional committed to delivering strategic, pragmatic solutions that ensure adherence to legal and regulatory obligations. With a focus on developing and implementing streamlined control frameworks, Chris optimises performance, minimises risk, and ensures compliance by promoting consistent, effective, and efficient practices.

Drawing on substantial expertise in data privacy, compliance, risk mitigation, and business transformation, Chris excels at navigating complex regulatory landscapes. His skillset encompasses project management, sales process design, and business process re-engineering, enabling him to create bespoke solutions tailored to organisational needs.

With hands-on experience spanning over 100 countries and a proven track record across a range of industries, Chris brings a unique, global perspective to data protection challenges at mdgroup.

As a regional leader, Leah thrives on working collaboratively with clients to enable them each to achieve their specific goals. Innovative and determined, she shapes ideas, concepts and approaches to fit their individual requirements, gaining satisfaction from playing her part in empowering others to do well.

Leah’s strengths lie in her organisational and development abilities. She focuses on supporting each person as an individual and making the team more effective as a whole. She isn’t happy until the client is and will work tirelessly to achieve that goal.

A process-driven and inclusive leader, Leah brings her expertise in account management and delivery across the medical communications and clinical research sectors to her current role.

Ian came to his position as Financial Director with a wealth of experience. He qualified as a Fellow Member of the Association of Chartered Certified Accountants in practice and has held senior financial roles in FTSE 100 companies around the world including GSK, Vodafone and K3 business technologies, a key partner for Microsoft.

Having been involved in large scale company growth during his career, Ian has implemented various accounting systems on a global level, reporting to financial compliance bodies where he has worked in the UK, North America and Europe.

Ian drives our corporate performance and profitability, maintaining the highest quality reporting across our global enterprise. He’s passionate about the mdgroup commitment to delivering remarkable results for our clients and takes a dynamic, strategic approach to mdgroup product development and innovation, keeping us at the forefront of the clinical research industry.